Early stage biotech developing targeted therapies for cancer.
Industry: Health Care
First Day Return: +108.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/04/2020 |
Offer Price | $18.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 11.8 |
Deal Size ($mm) | $212 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/24/2020 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $212 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cranbury, NJ, United States |
Founded | 2013 |
Employees at IPO | 39 |
Website www.pmvpharma.com |